These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24847999)

  • 21. Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention.
    Goldstein BI; Bukstein OG
    J Clin Psychiatry; 2010 Mar; 71(3):348-58. PubMed ID: 19961811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.
    Beaulieu S; Saury S; Sareen J; Tremblay J; Schütz CG; McIntyre RS; Schaffer A;
    Ann Clin Psychiatry; 2012 Feb; 24(1):38-55. PubMed ID: 22303521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does recovery from substance use disorder matter in patients with bipolar disorder?
    Weiss RD; Ostacher MJ; Otto MW; Calabrese JR; Fossey M; Wisniewski SR; Bowden CL; Nierenberg AA; Pollack MH; Salloum IM; Simon NM; Thase ME; Sachs GS;
    J Clin Psychiatry; 2005 Jun; 66(6):730-5; quiz 808-9. PubMed ID: 15960566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Difficulties in emotional regulation and substance use disorders: a controlled family study of bipolar adolescents.
    Wilens TE; Martelon M; Anderson JP; Shelley-Abrahamson R; Biederman J
    Drug Alcohol Depend; 2013 Sep; 132(1-2):114-21. PubMed ID: 23422834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Family-Focused Therapy vs Enhanced Usual Care for Symptomatic Youths at High Risk for Bipolar Disorder: A Randomized Clinical Trial.
    Miklowitz DJ; Schneck CD; Walshaw PD; Singh MK; Sullivan AE; Suddath RL; Forgey Borlik M; Sugar CA; Chang KD
    JAMA Psychiatry; 2020 May; 77(5):455-463. PubMed ID: 31940011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders.
    Matthews AM; Huckans MS; Blackwell AD; Hauser P
    Bipolar Disord; 2008 Mar; 10(2):266-70. PubMed ID: 18271905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of bipolar and substance use disorders in parents of adolescents with bipolar disorder.
    Wilens TE; Biederman J; Adamson J; Monuteaux M; Henin A; Sgambati S; Santry A; Faraone SV
    Biol Psychiatry; 2007 Jul; 62(2):129-34. PubMed ID: 17481590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bipolar Disorder and Comorbid Use of Illicit Substances.
    Preuss UW; Schaefer M; Born C; Grunze H
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy.
    Miklowitz DJ; Simoneau TL; George EL; Richards JA; Kalbag A; Sachs-Ericsson N; Suddath R
    Biol Psychiatry; 2000 Sep; 48(6):582-92. PubMed ID: 11018229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and correlates of bipolar I disorder among adults with primary youth-onset anxiety disorders.
    Goldstein BI; Levitt AJ
    J Affect Disord; 2007 Nov; 103(1-3):187-95. PubMed ID: 17328960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of family intervention on psychosocial functioning and mood symptoms of youth at high risk for bipolar disorder.
    Weintraub MJ; Schneck CD; Posta F; Merranko JA; Singh MK; Chang KD; Miklowitz DJ
    J Consult Clin Psychol; 2022 Feb; 90(2):161-171. PubMed ID: 35084893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study.
    Lagerberg TV; Andreassen OA; Ringen PA; Berg AO; Larsson S; Agartz I; Sundet K; Melle I
    BMC Psychiatry; 2010 Jan; 10():9. PubMed ID: 20105311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does conduct disorder mediate the development of substance use disorders in adolescents with bipolar disorder? A case-control family study.
    Wilens TE; Martelon M; Kruesi MJ; Parcell T; Westerberg D; Schillinger M; Gignac M; Biederman J
    J Clin Psychiatry; 2009 Feb; 70(2):259-65. PubMed ID: 19210945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttraumatic stress disorder and substance use disorder in adolescent bipolar disorder.
    Steinbuchel PH; Wilens TE; Adamson JJ; Sgambati S
    Bipolar Disord; 2009 Mar; 11(2):198-204. PubMed ID: 19267702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network.
    Nolen WA; Luckenbaugh DA; Altshuler LL; Suppes T; McElroy SL; Frye MA; Kupka RW; Keck PE; Leverich GS; Post RM
    Am J Psychiatry; 2004 Aug; 161(8):1447-54. PubMed ID: 15285972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of psychotherapy on comorbid bipolar disorder and substance use disorder: A systematic review.
    Crowe M; Eggleston K; Douglas K; Porter RJ
    Bipolar Disord; 2021 Mar; 23(2):141-151. PubMed ID: 32615028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: results from the FACE-BD cohort.
    Belzeaux R; Correard N; Boyer L; Etain B; Loftus J; Bellivier F; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Henry C; Azorin JM;
    J Affect Disord; 2013 Dec; 151(3):1009-15. PubMed ID: 24051101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective progression from high-prevalence disorders to bipolar disorder: Exploring characteristics of pre-illness stages.
    Ratheesh A; Cotton SM; Betts JK; Chanen A; Nelson B; Davey CG; McGorry PD; Berk M; Bechdolf A
    J Affect Disord; 2015 Sep; 183():45-8. PubMed ID: 26001662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are self-rated and behavioural measures of impulsivity in bipolar disorder mainly related to comorbid substance use problems?
    Bauer IE; Meyer TD; Sanches M; Spiker D; Zunta-Soares G; Soares JC
    Cogn Neuropsychiatry; 2017 Jul; 22(4):298-314. PubMed ID: 28490234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of the impact of co-occurring anxiety and substance use disorder on bipolar disorder illness outcomes in STEP-BD.
    Prisciandaro JJ; Mellick W; Mitaro E; Tolliver BK
    J Affect Disord; 2019 Mar; 246():794-799. PubMed ID: 30623826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.